Assyro AI

Orange Book product · Generic (ANDA)

BENZONATATE

BENZONATATE

Generic (ANDA)ANDA 202765TE AARX CSPC-NBP PHARM

At a glance

Aug 25, 2017

Approved

Generic (ANDA)

Application

AA

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 25, 2017

    8 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

BENZONATATE

Strength

100MG

Dosage form

CAPSULE

Route

ORAL

TE code

AA

Application

ANDA 202765

Product number

002

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of BENZONATATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.